medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2012, Number 4

<< Back Next >>

Rev Mex Patol Clin Med Lab 2012; 59 (4)

Hormone of darkness

Martínez HB, Sánchez MY, Urra TK, Thomas MYD, Burgos SJL

Language: Spanish
References: 31
Page: 222-232
PDF size: 57.32 Kb.


ABSTRACT

Introduction: Melatonin is secreted by the pineal gland or epiphysis from tryptophan, one of the twenty essential amino acids that constitute the living matter, it is inhibited by light and stimulated by darkness and it is produced synthetically in tablets, not only applied to insomnia, but also in anorexia and depression, with cytoprotective natural action, it prevents the cell damage phenomena and it acts as an “anti-aging” cellular and organic substance. Development: A bibliographic review was carried out where an updated data on the Melatonin hormone were collected. The fundamental purpose was to identify the main effects of the hormone, its relationship with the aging process and associated diseases.


REFERENCES

  1. Arendt J, Aldhous M, Writght J. Synchronization of a disturbed sleep- wake cycle in a blind man by melatonin treatment. Lacet 1988; 1 (8588): 772-773.

  2. Bellipanni G, DI Marzo A. Effects of melatonin in perimenopausal and menopausal woman: our personal experience. Ann N Y Acad Sci 2005; 1057: 303-402.

  3. Boutin J, Audinot V, Ferry G, Delagrange P. Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 2005; 26 (8): 412-419.

  4. Caniato R, Filippini R, Piovan A, Puricelli L, Borsarini A, Cappelletti E. Melatonin in plants. Adv Exp Med Biol 2003; 527: 593-597.

  5. Dodick D, Capobianco D. Treatment and management of cluster headache. Curr pain headache Resp 2005; 5 (1): 83-91.

  6. Gagnier J. The therapeutic potential of melatonin in migraines and other headache types. Altem Med Rev 2001; 6 (4): 383-389.

  7. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005; 27 (2): 119-130.

  8. Lewis A. Melatonin and the Biological Clock. New York, NY: Mc Graw-Hill; 2006. p. 7.

  9. Lincoln G, Andersson H, Luodon A. Clock genes in calendar cell as the basis of annual timekeeping in mammals- a unifying hypothesis. J Endocrinol 2006; 179 (1): 1-13.

  10. Maestroni G. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. Adv Exp Med Boil 2007; 467: 217-226.

  11. Zemlan FP, Mulchahey JJ, Scharf MB. The efficacy and safety of the melatonin agonist beta-methyl 6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial. J Clin Psychiatry 2005; 66 (3): 384-390.

  12. Melatonina y Depresión. Forumclinic 2006, web médica realizada por especialistas del Hospital Clínico de Barcelona. Disponible en: http://www.nlm.nih.gov/medilineplus/spanish/druginfo/natural/patient-melatonin.html.

  13. Lazar MA, Werner and Inguar. The Melatonin 6 the, Philadelphia, JB lippincott, 2005. Disponible en: http://www.dsalud.com/numero 83 5. html.

  14. Vassart G, Dumont JE: The melatonin receptor and the regulation, Function Endocrinal Rev. 13. 596,2005. Disponible en: http://www. Ine. es/seccioness/noticias.jspNumEjemplar= 1540& pld Seccion = 4 6&pldNoticia=490009.

  15. Lewwy Aj, Wehr TA, Butwin SK, et al. Light Supresses. Melatonin Secretoria in Humans. Science 2004; 210: 1267.

  16. Bosch FX, Robhan T, Schneider A, Frasear I, Pfister H, Castellsagué X et al. Melatonin research update: highlights of the Barcelona international conference. J Clin Pathol 2004; 54: 163-175.

  17. Archivo médico 2004 disponible en: http://wwww.cesdepu.com/decretos/28791-S.17-JUL-2000.htm.

  18. Salud hoy – Actualizado febrero de 2003. Disponible en: http://www.saludhoy.com/htm/exam/articulo/citolog2.html.

  19. Arnheim H, Erlich H. Polymerase Cain reaction strategy. Ann Rev Biochem 1999; 61: 131-156.

  20. Dodick D, Capobianco D. Treatment and management of cluster headache. Curr Pain Headache Resp 2005; 5 (1): 83-91.

  21. Jastreboff AM, Cymet T. Role of human melatonin in the development of and malignancy. Postgrad Med J 2002; 78: 225-228.

  22. MedNews 2005. Disponible en: http://www.ampersandisi.com/ginecoweb/cancer.htm.

  23. Christopher P. Human Mealtonin Type 16 early. N Engl J Med 2006; 2 (3): 310.

  24. Sentíes MH, Estañol VB. Cefalea en racimos. Med UIS [internet] 2009 sept-dic [citado 25 ene 2012]; 22 (3). Disponible en: file:///J:/LILACS%20-%20Resultado%20de%20la%20b%C3%BAsqueda%20%28p%C3%A1gina%201%29.html

  25. Mesa VMC, Rueda MM, Zayas CR, Sicard SD, Groot RH. Acción protectora de la melatonina sobre células mononucleares de sangre periférica humana sometidas a radiación gamma Co60. Univ Sci; [internet]. 2009 ene-abr [citado 25 ene 2012]; 14 (1). Disponible en: file:///G:/LILACS%20%20Resultado%20de%20la%20b%C3%BAsqueda%20(p%C3%A1gina%201).htm

  26. Bastos FF. Melatonina, isoenzimas de glutationa S-transferases e estresse oxidante em pacu Piaractus mesopotamicus. Rio de Janeiro [internet]. 2010[citado 28 ene 2012]. Disponible en: file:///G:/LILACS%20 %20Resultado%20de%20la%20b%C3%BAsqueda%20(p%C3%A1gina%201).htm

  27. Reis LC, Gomes R, da Silva SA, Borges CJ, de Souza L, Spadaro F, Santos MB, Collus OL. Alterações metabólicas e da bioquímica plasmática após pinealectomia em ratos. Rev Med Minas Gerais [internet]. jul.-sept. 1996. [citado 28 ene 2012]; 6 (3) file:///G:/LILACS%20-%20Resultado%20de%20la%20b%C3%BAsqueda%20(p%C3%A1gina%201).htm

  28. Aktas AT, Yildirim A, Nergiz Y, Akkus M. Protectores de la Melatonina en el Daño por Torsión y Destorsión Testicular en Ratas Sprague-Dawley. Int J Morphol [internet]. 2011 Mar [citado 28 ene 2012]; 29 (1). Disponible en: file:///G:/LILACS%20-%20Resultado%20de%20la%20b%C3%BAsqueda%20(p%C3%A1gina%201).htm

  29. Saad Krime, R Luiz Carlos. Influência da melatonina sobre o desenvolvimento corporal e ósseo de ratos. Rev Med Minas Gerais [internet]. out-dez 2004, [citado 28 ene 2012]; 4 (4). Disponible en: file:///G:/LILACS%20-%20Resultado%20de%20la%20b%C3%BAsqueda%20(p%C3%A1gina%201).htm

  30. Ferreira da Silva C et al. Melatonina: modulador de morte celular Rev Assoc Med Bras [internet]. 2010. [citado 28 ene 2012]; (6): 715-718. Disponible en: file:///G:/LILACS%20-%20Resultado%20de%20la%20b%C3%BAsqueda%20(p%C3%A1gina%201).htm

  31. Fchs Luiz Portugal G et al. Ação da melatonina sobre a apoptose e fator de crescimento endotelial vascular no córtex da adrenal de ratas pinealectomizadas. Rev Bras Ginecol Obstet. [internet]. 2010. agos [citado 25 ene 2012]; 32 (8). Disponible en: file:///G:/LILACS%20-%20Resultado%20de%20la%20b%C3%BAsqueda%20(p%C3%A1gina%201).htm




2020     |     www.medigraphic.com